147 related articles for article (PubMed ID: 1854833)
1. Retroviral oncogenes: interrelationships between neoplastic transformation and cell differentiation.
Auersperg N; Roskelley C
Crit Rev Oncog; 1991; 2(2):125-60. PubMed ID: 1854833
[No Abstract] [Full Text] [Related]
2. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
3. Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation.
Kansara M; Berridge MV
Anticancer Res; 2004; 24(4):2503-10. PubMed ID: 15330205
[TBL] [Abstract][Full Text] [Related]
4. The effect of oncogenes on the growth and differentiation of oligodendrocyte type 2 astrocyte progenitor cells.
Barnett SC; Crouch DH
Cell Growth Differ; 1995 Jan; 6(1):69-80. PubMed ID: 7718486
[TBL] [Abstract][Full Text] [Related]
5. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
[TBL] [Abstract][Full Text] [Related]
6. Cell type-specific tumor induction in neural transplants by retrovirus-mediated oncogene transfer.
Aguzzi A; Kleihues P; Heckl K; Wiestler OD
Oncogene; 1991 Jan; 6(1):113-8. PubMed ID: 1992439
[TBL] [Abstract][Full Text] [Related]
7. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
[TBL] [Abstract][Full Text] [Related]
8. [Malignant cell transformation and oncogenes].
Kiselev FL
Genetika; 1985 Jun; 21(6):885-95. PubMed ID: 3928437
[TBL] [Abstract][Full Text] [Related]
9. TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line.
Portella G; Vitagliano D; Li Z; Sferratore F; Santoro M; Vecchio G; Fusco A
Oncol Res; 1998; 10(9):441-7. PubMed ID: 10223619
[TBL] [Abstract][Full Text] [Related]
10. Cancer: is there involved a bunch of culprits, one culprit, or something in between?
Svoboda J
Folia Biol (Praha); 2000; 46(6):219-25. PubMed ID: 11140854
[No Abstract] [Full Text] [Related]
11. Retroviral v-myc infection of primary fetal liver cells: transformation of monocytes in vitro.
Birchenall-Roberts MC; Engelmann GL; Keller JR; Lohrey N; Ruscetti FW
Oncogene; 1989 Jun; 4(6):731-5. PubMed ID: 2786619
[TBL] [Abstract][Full Text] [Related]
12. Suppression of cellular transformation by glucocorticoid receptor mutants.
Kameda T; Iba H
Cancer Res; 1998 Mar; 58(5):867-70. PubMed ID: 9500440
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes in cellular immortalisation and differentiation (review).
Gonos ES; Spandidos DA
Anticancer Res; 1993; 13(4):1117-22. PubMed ID: 8352534
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
Spandidos DA
J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
[TBL] [Abstract][Full Text] [Related]
15. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
16. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
17. Immortalization and malignant transformation of differentiated cells by oncogenes in vitro and in transgenic mice.
Paul D; Schmidt GH
Crit Rev Oncog; 1989; 1(3):307-21. PubMed ID: 2488135
[No Abstract] [Full Text] [Related]
18. Malignant transformation of an epithelial cell by v-Src via tv-a-mediated retroviral infection: a new cell model for studying carcinogenesis.
Fu SL; Huang YJ; Liang FP; Huang YF; Chuang CF; Wang SW; Yao JW
Biochem Biophys Res Commun; 2005 Dec; 338(2):830-8. PubMed ID: 16256070
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
20. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]